- Home
- PURR vs CASI Comparison
PURR vs CASI Comparison
Compare PURR & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$3.26
HOLD
Current Price
$0.79
Company Overview
Basic Information| Metric | PURR | CASI |
|---|---|---|
| Founded | 2025 | 1991 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.9M | 24.9M |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | PURR | CASI |
|---|---|---|
| Price | $3.26 | $0.79 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $6.58 | $4.00 |
| AVG Volume (30 Days) | ★ 1.5M | 34.8K |
| Earning Date | 01-01-0001 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $26,846,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 21.72 |
| 52 Week Low | $3.15 | $0.75 |
| 52 Week High | $4.65 | $3.47 |
Technical Indicators
Market Signals| Indicator | PURR | CASI |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 28.05 |
| Support Level | N/A | $0.83 |
| Resistance Level | N/A | $0.95 |
| Average True Range (ATR) | 0.00 | 0.09 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 0.00 | 0.00 |
Price Performance
Historical Comparison PURR
CASI
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.